Shan Wu

Shan Wu currently serves as the Chief Business Officer, bringing a robust educational background with a Ph.D. in Biological Engineering from the Massachusetts Institute of Technology and a B.S. in Computer and Electrical Engineering from the University of Virginia. Wu’s career includes significant roles in the biotechnology industry, such as Vice President and head of business development, investor relations, and alliance management at Magenta Therapeutics. Additionally, Wu led strategic forecasting for the multiple sclerosis global commercial organization at Biogen and was a management consultant at Clarion Healthcare. During his tenure at Clarion, he led projects focused on therapeutic area strategy, product differentiation strategy, market opportunity assessment, and global launch planning.